<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00318591</url>
  </required_header>
  <id_info>
    <org_study_id>DK046CC</org_study_id>
    <nct_id>NCT00318591</nct_id>
  </id_info>
  <brief_title>Comparative Study of Intermittent Catheters and Occurrence of Urinary Tract Infections</brief_title>
  <official_title>A Prospective, Randomized, Parallel-group, Multi-center Study to Compare the Occurrence of Urinary Tract Infections in Patients With Spinal Cord Injury Using Either Coated or Uncoated Intermittent Catheters.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Coloplast A/S</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Coloplast A/S</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the frequency of urinary tract infections with
      symptoms in spinal cord injured patients requiring intermittent catheterization for emptying
      the bladder. Patients will use either a coated catheter or an uncoated catheter with gel.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Introduction:

      Spinal cord injured (SCI) constitutes a large group of patients suffering from neurogenic
      bladder dysfunction, which is often managed by intermittent catheterization (IC).
      Intermittent catheterization is accepted as a safe and effective method for maintaining
      bladder and renal health in individuals with neurogenic bladder dysfunction. However, IC
      several times a day places an individual at risk for urethral trauma, hematuria, and
      particularly symptomatic urinary tract infections (UTI).

      Attempts to control UTI with prophylactic antibiotics or sterile technique have not been
      overly successful but more recent advances in catheter technology, such as the
      hydrophilic-coated catheter, offer potential benefit. The hydrophilic-coated catheter has a
      slippery, pre-lubricated surface (along the entire length of the catheter) when soaked in
      water, allowing smooth insertion without the need for additional water soluble lubricant. Two
      proposed advantages over uncoated catheters are 1) reduced incidence of symptomatic UTI, and
      2) reduction of urethral irritation or urethral trauma, and lowered risk of urethral
      strictures. Currently, while there are trends in favour of hydrophilic-coated catheters with
      respect to UTI overall evidence remains inadequate for clinical decision-making for choice of
      catheter type. Randomised trials to date have been limited by short follow up, heterogeneity,
      attrition, imprecise outcome measures, and varying definitions of UTI5. Conclusions of the
      Cochrane group in 20076 were echoed in a recent comprehensive re-view of all studies on
      hydrophilic-coated catheters - there is modest evidence favouring hydrophilic-coated catheter
      in reduction of UTI, but further robust research is required.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2006</start_date>
  <completion_date type="Actual">October 2009</completion_date>
  <primary_completion_date type="Actual">October 2009</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Occurrence of Symptomatic Urinary Tract Infections (UTIs)</measure>
    <time_frame>4-6 months</time_frame>
    <description>Occurrence of symptomatic urinary tract infections (UTIs). Time to first UTI</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>UTIs With Bacteriuria &gt;=100 Colony Forming Units (CFU)/ml</measure>
    <time_frame>4-6 months</time_frame>
    <description>UTIs with bacteriuria &gt;=100 Colony Forming Units (CFU)/ml. Descriptive analysis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nurse Evaluation of Catheters - Overall Satisfaction</measure>
    <time_frame>4-6 months</time_frame>
    <description>Evaluation score on an 11-point scale from 0-10 (0 being lowest satisfaction)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient or Caregiver's Evaluation of Catheters - Overall Satisfaction</measure>
    <time_frame>4-6 months</time_frame>
    <description>Evaluation score on an 11-point scale from 0-10 (0 being lowest satisfaction)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nurse Time Spent on Catheterization Procedure</measure>
    <time_frame>4-6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Device-related or Possibly Device-related AEs</measure>
    <time_frame>4-6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With One or More Urinary Tract Infection</measure>
    <time_frame>4-6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">219</enrollment>
  <condition>Urinary Tract Infections</condition>
  <arm_group>
    <arm_group_label>SpeediCath</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>hydrophilic-coated intermittent catheter</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conveen Uncoated</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>uncoated urinary intermittent catheter</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>SpeediCath</intervention_name>
    <description>hydrophilic coated urinary intermittent catheter</description>
    <arm_group_label>SpeediCath</arm_group_label>
    <other_name>Coated Catheter</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Conveen Uncoated</intervention_name>
    <description>Uncoated urinary intermittent catheter</description>
    <arm_group_label>Conveen Uncoated</arm_group_label>
    <other_name>Uncoated catheter</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Traumatic spinal cord injury within 3 months prior to inclusion

          -  Neurogenic bladder dysfunction requiring intermittent catheterization at least 3 times
             daily

        Exclusion Criteria:

          -  Has symptoms of UTI at inclusion

          -  Treated with prophylactic antibiotics to prevent UTIs

          -  Has a history of unresolved bladder-ureteral reflux and/or stones in the urinary tract

          -  Has used intermittent catheterization for more than 10 days prior to inclusion
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Diana Cardenas, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Miami</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Rancho Los Amigos National Rehabilitation Center</name>
      <address>
        <city>Downey</city>
        <state>California</state>
        <zip>90242</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Santa Clara Valley Medical Center</name>
      <address>
        <city>San Jose</city>
        <state>California</state>
        <zip>95128</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Craig Hospital</name>
      <address>
        <city>Englewood</city>
        <state>Colorado</state>
        <zip>80113</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Miami</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33101</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Shepherd Center</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30309</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Boston Medical School</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02188</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Michigan Helaths Systems</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48108</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic, Saint Mary Hospital MB3CF Rehabilitation</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55902</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kessler Institute for Rehabilitation</name>
      <address>
        <city>West Orange</city>
        <state>New Jersey</state>
        <zip>07052</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mount Sinai School of Medicine</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Carolinas Medical Center</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28303</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Institute for Rehabilitation and Research (TIRR)</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Alberta</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <zip>T6G 2C8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>G.F.Strong Rehabilitation Centre</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <zip>V5Z 2G9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Parkwood Rehabilitation Centre</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <zip>N6A 4G5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Toronto Rehabilitation Centre</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M4G 3V9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 26, 2006</study_first_submitted>
  <study_first_submitted_qc>April 26, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 27, 2006</study_first_posted>
  <results_first_submitted>February 23, 2011</results_first_submitted>
  <results_first_submitted_qc>April 26, 2011</results_first_submitted_qc>
  <results_first_posted type="Estimate">May 25, 2011</results_first_posted>
  <last_update_submitted>August 6, 2015</last_update_submitted>
  <last_update_submitted_qc>August 6, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 24, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Urinary Tract Infections</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>SpeediCath</title>
          <description>Hydrophilic coated intermittent catheter</description>
        </group>
        <group group_id="P2">
          <title>Conveen Uncoated</title>
          <description>Uncoated intermittent catheter</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="105"/>
                <participants group_id="P2" count="114"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="45"/>
                <participants group_id="P2" count="69"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="60"/>
                <participants group_id="P2" count="45"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>SpeediCath</title>
          <description>Hydrophilic coated intermittent catheter</description>
        </group>
        <group group_id="B2">
          <title>Conveen Uncoated</title>
          <description>Uncoated intermittent catheter</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="105"/>
            <count group_id="B2" value="114"/>
            <count group_id="B3" value="219"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="37.2" spread="14.4"/>
                    <measurement group_id="B2" value="35.1" spread="13.2"/>
                    <measurement group_id="B3" value="36.1" spread="13.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <description>Gender is unknown for one participant</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="83"/>
                    <measurement group_id="B2" value="93"/>
                    <measurement group_id="B3" value="176"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="80"/>
                    <measurement group_id="B2" value="86"/>
                    <measurement group_id="B3" value="166"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Canada</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                    <measurement group_id="B2" value="28"/>
                    <measurement group_id="B3" value="53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Occurrence of Symptomatic Urinary Tract Infections (UTIs)</title>
        <description>Occurrence of symptomatic urinary tract infections (UTIs). Time to first UTI</description>
        <time_frame>4-6 months</time_frame>
        <population>ITT-population, symptomatic urinary tract infections treated with antibiotics</population>
        <group_list>
          <group group_id="O1">
            <title>SpeediCath Catheter</title>
            <description>Hydrophilic coated intermittent catheter</description>
          </group>
          <group group_id="O2">
            <title>Conveen Uncoated</title>
            <description>uncoated intermittent catheter</description>
          </group>
        </group_list>
        <measure>
          <title>Occurrence of Symptomatic Urinary Tract Infections (UTIs)</title>
          <description>Occurrence of symptomatic urinary tract infections (UTIs). Time to first UTI</description>
          <population>ITT-population, symptomatic urinary tract infections treated with antibiotics</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="105"/>
                <count group_id="O2" value="114"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Free of UTIs from study start to day 30</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19" spread="0"/>
                    <measurement group_id="O2" value="20" spread="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Free of UTIs from study start to day 150</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>The analysis was done by comparing Kaplan-Meier estimates of the survival function of the two groups. The analysis was refined by a Cox proportional hazards regression model for survival data.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>The additional explanatory variables were removed using backwards-elimination removing the least significant additional variable for each iteration, until the effect of all included additional variables was significant on α=0.05 significant level. The null-hypothesis of no catheter difference was to be rejected on α=0.05 significant level.</non_inferiority_desc>
            <p_value>0.0383</p_value>
            <p_value_desc>p-value is adjusted for the following explanatory variables: catheterization frequency, technique (clean/sterile), procedure (participant/nurse), setting (hospital/community) and demographic measures.</p_value_desc>
            <method>Kaplan-Meier</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>1.502</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.022</ci_lower_limit>
            <ci_upper_limit>2.207</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>UTIs With Bacteriuria &gt;=100 Colony Forming Units (CFU)/ml</title>
        <description>UTIs with bacteriuria &gt;=100 Colony Forming Units (CFU)/ml. Descriptive analysis</description>
        <time_frame>4-6 months</time_frame>
        <population>Descriptive only</population>
        <group_list>
          <group group_id="O1">
            <title>SpeediCath Catheter</title>
            <description>Hydrophilic coated intermittent catheter</description>
          </group>
          <group group_id="O2">
            <title>Conveen Uncoated</title>
            <description>Uncoated intermittent catheter</description>
          </group>
        </group_list>
        <measure>
          <title>UTIs With Bacteriuria &gt;=100 Colony Forming Units (CFU)/ml</title>
          <description>UTIs with bacteriuria &gt;=100 Colony Forming Units (CFU)/ml. Descriptive analysis</description>
          <population>Descriptive only</population>
          <units>UTI</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="105"/>
                <count group_id="O2" value="114"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="101"/>
                    <measurement group_id="O2" value="151"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Nurse Evaluation of Catheters - Overall Satisfaction</title>
        <description>Evaluation score on an 11-point scale from 0-10 (0 being lowest satisfaction)</description>
        <time_frame>4-6 months</time_frame>
        <population>Analysis were done on evaluations of the ITT-population. Evaluations were made at discharge from hospital. Since some participants discontinued the study prior to discharge and since some did not fill in the evaluation form, the total number of evaluations (132) do not add up to the total of the ITT population (219)</population>
        <group_list>
          <group group_id="O1">
            <title>SpeediCath</title>
            <description>Hydrophilic coated intermittent catheter</description>
          </group>
          <group group_id="O2">
            <title>Conveen Uncoated</title>
            <description>Uncoated intermittent catheter</description>
          </group>
        </group_list>
        <measure>
          <title>Nurse Evaluation of Catheters - Overall Satisfaction</title>
          <description>Evaluation score on an 11-point scale from 0-10 (0 being lowest satisfaction)</description>
          <population>Analysis were done on evaluations of the ITT-population. Evaluations were made at discharge from hospital. Since some participants discontinued the study prior to discharge and since some did not fill in the evaluation form, the total number of evaluations (132) do not add up to the total of the ITT population (219)</population>
          <units>scores on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="59"/>
                <count group_id="O2" value="73"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.1" spread="2.3"/>
                    <measurement group_id="O2" value="8.3" spread="2.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>ANOVA analysis. Limit of significant difference &lt;0.05</non_inferiority_desc>
            <p_value>0.7670</p_value>
            <p_value_desc>baseline characteristics were used as covariates, catheterization procedure (participant or caregiver) as well as technique (sterile or clean). Backward elimination was used.</p_value_desc>
            <method>ANOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patient or Caregiver's Evaluation of Catheters - Overall Satisfaction</title>
        <description>Evaluation score on an 11-point scale from 0-10 (0 being lowest satisfaction)</description>
        <time_frame>4-6 months</time_frame>
        <population>ITT population</population>
        <group_list>
          <group group_id="O1">
            <title>SpeediCath</title>
            <description>Hydrophilic coated intermittent catheter</description>
          </group>
          <group group_id="O2">
            <title>Conveen Uncoated</title>
            <description>Uncoated intermittent catheter</description>
          </group>
        </group_list>
        <measure>
          <title>Patient or Caregiver's Evaluation of Catheters - Overall Satisfaction</title>
          <description>Evaluation score on an 11-point scale from 0-10 (0 being lowest satisfaction)</description>
          <population>ITT population</population>
          <units>scores on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
                <count group_id="O2" value="61"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.3" spread="1.4"/>
                    <measurement group_id="O2" value="8.6" spread="1.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>ANOVA. Level of significant difference &lt;0.05</non_inferiority_desc>
            <p_value>0.0074</p_value>
            <p_value_desc>baseline characteristics were used as covariates, catheterization procedure (participant or caregiver) as well as technique (sterile or clean). Backward elimination was used.</p_value_desc>
            <method>ANOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Nurse Time Spent on Catheterization Procedure</title>
        <time_frame>4-6 months</time_frame>
        <population>ITT-population</population>
        <group_list>
          <group group_id="O1">
            <title>SpeediCath</title>
            <description>Hydrophilic coated intermittent catheter</description>
          </group>
          <group group_id="O2">
            <title>Conveen Uncoated</title>
            <description>Uncoated intermittent catheter</description>
          </group>
        </group_list>
        <measure>
          <title>Nurse Time Spent on Catheterization Procedure</title>
          <population>ITT-population</population>
          <units>seconds</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="38"/>
                <count group_id="O2" value="53"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="337" spread="44"/>
                    <measurement group_id="O2" value="278" spread="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Device-related or Possibly Device-related AEs</title>
        <time_frame>4-6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>SpeediCath</title>
            <description>Hydrophilic coated intermittent catheter</description>
          </group>
          <group group_id="O2">
            <title>Conveen Uncoated</title>
            <description>Uncoated intermittent catheter</description>
          </group>
        </group_list>
        <measure>
          <title>Device-related or Possibly Device-related AEs</title>
          <units>Events</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="105"/>
                <count group_id="O2" value="114"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16"/>
                    <measurement group_id="O2" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With One or More Urinary Tract Infection</title>
        <time_frame>4-6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>SpeediCath</title>
            <description>Hydrophilic coated intermittent catheter</description>
          </group>
          <group group_id="O2">
            <title>Conveen Uncoated</title>
            <description>Uncoated intermittent catheter</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With One or More Urinary Tract Infection</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="105"/>
                <count group_id="O2" value="114"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="47"/>
                    <measurement group_id="O2" value="82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>SpeediCath</title>
          <description>Hydrophilic coated intermittent catheter</description>
        </group>
        <group group_id="E2">
          <title>Conveen Uncoated</title>
          <description>Uncoated intermittent catheter</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="105"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="114"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>deep vein thrombosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="105"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="114"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>diarrhea</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="105"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="114"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>subdural hematoma</sub_title>
                <description>not device-related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="105"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="114"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>suicidal ideation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="105"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="114"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="105"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="114"/>
              </event>
              <event>
                <sub_title>urosepsis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="105"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="114"/>
              </event>
              <event>
                <sub_title>perforated bladder/cystitis/decreased oxygen saturation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="105"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="114"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="105"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="114"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>1</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="105"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="114"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>renal and urinary disorders</sub_title>
                <counts group_id="E1" events="16" subjects_affected="16" subjects_at_risk="105"/>
                <counts group_id="E2" events="13" subjects_affected="13" subjects_at_risk="114"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>reproductive system and breast disorders</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="105"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="114"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Anna Karina Busch, Intl. Senior Scientific Manager</name_or_title>
      <organization>Coloplast</organization>
      <phone>+45 49112350</phone>
      <email>dkakb@coloplast.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

